tiprankstipranks
Advertisement
Advertisement

Nutritional Growth Solutions Chair Updates Shareholding Disclosure After Late Appendix 3Y Filing

Story Highlights
  • Nutritional Growth Solutions’ new Chair Andrew Grover filed a late director interest notice to disclose spouse-controlled shares subscribed before his appointment.
  • The board says the delayed Appendix 3Y stems from governance considerations, not systemic issues, and reiterates confidence in its compliance framework.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nutritional Growth Solutions Chair Updates Shareholding Disclosure After Late Appendix 3Y Filing

Claim 55% Off TipRanks

The latest update is out from Nutritional Growth Solutions Ltd. ( (AU:NGS) ).

Nutritional Growth Solutions has disclosed that its newly appointed Chair, Andrew Grover, has lodged a Change of Director’s Interest Notice later than the timeframe set out in ASX Listing Rule 3.19A, after choosing to include shares exclusively controlled by his spouse that were subscribed for before he joined the board. Although Grover has no relevant interest in these shares, the board says the disclosure aligns with his practices at another listed company and is intended to address any perceived conflicts, emphasising that the delay does not indicate a systemic compliance issue and reaffirming confidence in the company’s governance and continuous disclosure controls.

The most recent analyst rating on (AU:NGS) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Nutritional Growth Solutions Ltd. stock, see the AU:NGS Stock Forecast page.

More about Nutritional Growth Solutions Ltd.

Nutritional Growth Solutions Ltd. is a U.S.-based health, nutrition and wellness company that develops, produces and sells clinically tested nutritional supplement formulas for children, built on two decades of pediatric nutrition research. The company targets the underserved three- to twelve-year-old segment of the nutritional supplements market, differentiating itself with clinically validated products and a growing portfolio aimed at this larger growth opportunity.

Average Trading Volume: 290,959

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$6.66M

See more insights into NGS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1